TGFA and liver cancer: Considering the upregulation of TGFα in human malignancies, including liver cancer, hope focuses on the possible therapeutic benefit of blocking TGFα-evoked signal transduction on the cell surface, for example, by blockade of the receptor or of ligand–receptor interactions (Levitzki and Gazit, 1995; Mendelsohn, 1997).